Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …

In the last 10 years, extended-spectrum β-lactamase-producing enterobacteria (ESBL-E)
have become one of the main challenges for antibiotic treatment of enterobacterial infections, …

Autosomal inborn errors of type I IFN immunity and autoantibodies against these cytokines
underlie at least 10% of critical COVID-19 pneumonia cases. We report very rare, …

Importance The benefit of high-dose dexamethasone and oxygenation strategies vs standard
of care for patients with severe acute hypoxemic respiratory failure (AHRF) caused by …

Background Interpretation of the evidence from randomised controlled trials (RCTs) of
remdesivir in patients treated in hospital for COVID-19 is conflicting. We aimed to assess the …

Background Shortening the duration of antibiotic therapy for patients admitted to hospital
with community-acquired pneumonia should help reduce antibiotic consumption and thus …

Background Antibiotics are life-saving drugs but severely affect the gut microbiome with
short-term consequences including diarrhea and selection of antibiotic-resistant bacteria. Long-…

Background Multiplex polymerase chain reaction (mPCR) enables recovery of viruses from
airways of patients with community-acquired pneumonia (CAP), although their clinical impact …

Objectives We evaluated the clinical, virological and safety outcomes of lopinavir/ritonavir,
lopinavir/ritonavir–interferon (IFN)-β-1a, hydroxychloroquine or remdesivir in comparison to …

… plan was constructed by France Mentre and Charles Burdet. Christine Katlama, André Cabié
… Charles Burdet, Marie Vigan and France Mentre undertook the statistical analysis. Anne-…